Mesothelioma is a notoriously difficult asbestos related cancer to treat. Most chemotherapy drugs that have been used to treat this type of asbestos cancer have not had appreciable success in the treatment of this deadly cancer.
Among recently approved medications, Alimta stands out as having the most promise in prolonging the life of mesothelioma patients, as well as improving their quality of life.
Alimta, also known as Pemetrexed is a newer chemotherapy medication that was approved by the Food and Drug Administration (FDA) in 2005. Most times it used in combination with Cisplatin ,and Alimta is the first medication that is specifically approved for the treatment of mesothelioma and is considered to be the most effective chemotherapy treatment for pleural mesothelioma patients especially those that have advanced cancer that are not candidates for surgery. Continue reading ‘Mesothelioma Chemotherapy-What is the Role of Alimta?’ »